The interplay between psychoactive substances and mental health pathology remains one of the most clinically complex – and increasingly prevalent – presentations in modern psychiatry. Despite frequent public discourse around “drug misuse” and “mental illness,” the nuanced relationship between these domains is often obscured by stigma1, misinformation2, and oversimplistic cause-effect narratives. Across UK clinical settings, the incidence…